Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study

Author

V. Hoffman

J. Hallas

M. Linder

A. Margulis

B. Suehs

A. Arana

K. Phiri

C. Enger

L. Horter

I. Odsbu

M. Olesen

S. Perez-Gutthann

Y. Xu

N. Kristiansen

K. Appenteng

S. de Vogel

J. Seeger

Year of Publication

2021

DOI

10.1007/s40264-021-01095-7

• DOI
• Google Scholar
• BibTeX
• EndNote X3 XML
• EndNote 7 XML
• Endnote tagged
• Marc
• RIS